Dr Reddy's Lab Sept qtr net profit down 9.5% to Rs 13.42 billion

Hyderabad: Dr. Reddy's Laboratories, an Indian generic pharmaceutical company, announced on Tuesday that its second-quarter profits were impacted by one-time charges associated with its joint venture with Nestlé India and the acquisition of Nicotinell, reported Reuters

Dr Reddy’s Lab Q4FY24 net profit up 36% YoY to Rs 1,307 cr

Mumbai: Hyderabad-based pharma major Dr Reddy’s Laboratories recorded a net profit of Rs 1,307 crore in the March quarter of FY24, up 36 percent from the same period last year when it reported a profit of Rs 960 crore.

Dr Reddy's Q4FY23 consolidated PAT jumps 996 pc YoY to Rs 959 cr

Hyderabad: Hyderabad-based Pharma giant Dr Reddy’s Lab on Wednesday reported a consolidated net profit of Rs 959 crore for the fourth quarter ended March 2023, up 996 percent over Rs 87.5 crore reported in the corresponding quarter in the previous year.